Skip to main content

Benzinga's Top Upgrades, Downgrades For December 15, 2017

By: via Benzinga
Top Upgrades Analysts at Goldman Sachs upgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) from Neutral to Buy. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.